We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 130 results
  1. Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice

    Aims/hypothesis

    Lysophosphatidic acid (LPA) is a lipid mediator produced by adipocytes that acts via specific G-protein-coupled receptors; its...

    C. Rancoule, C. Attané, ... J. S. Saulnier-Blache in Diabetologia
    Article 19 March 2013
  2. Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy

    The proinflammatory lysophosphatidic acid (LPA) is a potent activator of several transcriptional factors and signaling pathways and a potent...

    Ahmed M. Abu El-Asrar, Ghulam Mohammad, ... Ghislain Opdenakker in Acta Diabetologica
    Article 04 August 2012
  3. Anti-Fibrosis Therapy and Diabetic Nephropathy

    Diabetes mellitus is rapidly becoming a global health issue that may overtake cancer during the next two decades as it covertly affects multiple...

    Anil Karihaloo in Current Diabetes Reports
    Article 29 May 2012
  4. Fibrosis in systemic sclerosis: common and unique pathobiology

    Fibrosis in systemic sclerosis (SSc), a complex polygenic disease associated with autoimmunity and proliferative/obliterative vasculopathy, shares...

    Swati Bhattacharyya, Jun Wei, ... John Varga in Fibrogenesis & Tissue Repair
    Article Open access 06 June 2012
  5. Cyclic regulation of LPA3 in human endometrium

    Background

    Lysophosphatidic acid (LPA) belongs to the group of lipid messengers, which plays a pivotal role in the establishment of implantation via...

    H. Guo, F. Gong, ... G. X. Lu in Archives of Gynecology and Obstetrics
    Article 08 August 2012
  6. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression

    Lysophosphatidic acid (LPA), produced extracellularly by autotaxin (ATX), has diverse biological activities implicated in tumor initiation and...

    S Y Park, K J Jeong, ... H Y Lee in Oncogene
    Article 22 November 2010
  7. Progesterone produces antinociceptive and neuroprotective effects in rats with microinjected lysophosphatidic acid in the trigeminal nerve root

    Background

    In our present study, we studied the role of demyelination of the trigeminal nerve root in the development of prolonged nociceptive...

    Min Ji Kim, Hea Jung Shin, ... Dong Kuk Ahn in Molecular Pain
    Article Open access 19 March 2012
  8. Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells

    Lysophosphatidic acid (LPA), which is a bioactive phospholipid, interacts with specific G protein-coupled transmembrane receptors. Recently,...

    Megumu Tsu**o, Minako Fujii, ... Toshifumi Tsujiuchi in Virchows Archiv
    Article 03 October 2010
  9. Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine

    Background

    Although neuropathic pain is frequently observed in demyelinating diseases such as Guillain-Barré syndrome and multiple sclerosis, the...

    Jun Nagai, Hitoshi Uchida, ... Hiroshi Ueda in Molecular Pain
    Article Open access 09 November 2010
  10. Metastasis-suppressor genes in clinical practice: lost in translation?

    Over the past 25 years, an expanding set of metastasis-suppressor genes (MSGs) has been identified that specifically regulate metastasis formation...

    Alexander N. Shoushtari, Russell Z. Szmulewitz, Carrie W. Rinker-Schaeffer in Nature Reviews Clinical Oncology
    Article 26 April 2011
  11. Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer

    Sphingosine kinase 1 (SK1) is a lipid enzyme with oncogenic properties that converts the proapoptotic lipid sphingosine into the antiapoptotic lipid...

    Dmitri Pchejetski, Torsten Böhler, ... Jonathan Waxman in Nature Reviews Urology
    Article 13 September 2011
  12. Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCϵ pathway in dorsal root ganglion neurons

    Background

    It has been demonstrated that lysophosphatidic acid (LPA) released from injury tissue and transient receptor potential vanilloid 1 (TRPV1)...

    Hai-Li Pan, Yu-Qiu Zhang, Zhi-Qi Zhao in Molecular Pain
    Article Open access 01 December 2010
  13. Differential roles for the p101 and p84 regulatory subunits of PI3Kγ in tumor growth and metastasis

    Phosphoinositide 3-kinase γ (PI3Kγ) consists of a catalytic subunit p110γ, which forms mutually exclusive dimers with one of the regulatory subunits...

    J A Brazzatti, M Klingler-Hoffmann, ... S R McColl in Oncogene
    Article 26 September 2011
  14. Molecular Targeted Therapy in Ovarian Cancer

    Over the past two decades, empirical optimization of cytotoxic chemotherapy combinations and surgical debulking procedures have improved outcomes and...

    Roshni Kalachand, Bryan T. Hennessy, Maurie Markman in Drugs
    Article 01 May 2011
  15. Antinociceptive effect of cyclic phosphatidic acid and its derivative on animal models of acute and chronic pain

    Background

    Cyclic phosphatidic acid (cPA) is a structural analog of lysophosphatidic acid (LPA), but possesses different biological functions, such as...

    Yasutaka Kakiuchi, Jun Nagai, ... Kimiko Murakami-Murofushi in Molecular Pain
    Article Open access 14 May 2011
  16. Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells

    Lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are bioactive lysophospholipids that affect various cellular processes through G...

    Ryota Itoh, Shigenori Miura, ... Yuji Hiraki in Journal of Bone and Mineral Metabolism
    Article 11 May 2010
  17. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management

    Interstitial lung disease (ILD) is a challenging clinical entity associated with multiple connective tissue diseases, and is a significant cause of...

    Flavia V Castelino, John Varga in Arthritis Research & Therapy
    Article 23 August 2010
  18. The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cells

    We have previously shown that high expression levels of the lipid kinase sphingosine kinase-1 (SphK1) correlate with poor survival of glioblastoma...

    Adriana Estrada-Bernal, Sean E. Lawler, ... James R. Van Brocklyn in Journal of Neuro-Oncology
    Article 12 October 2010
Did you find what you were looking for? Share feedback.